Table 1.
Relationship between the expression levels of hsa_circ_0001944 and clinicopathological features in bladder cancer
| Characteristics | No. (%) | hsa_circ_0001944 expression | ||
|---|---|---|---|---|
| Low (%) | High (%) | P-value | ||
| Gender | ||||
| Male | 42 (46.7) | 23 (54.8) | 19 (45.2) | 0.347 |
| Female | 48 (53.3) | 29 (60.4) | 19 (39.6) | |
| Age | ||||
| < 65 | 38 (42.2) | 20 (52.6) | 18 (47.4) | 0.186 |
| ≥ 65 | 52 (57.8) | 32 (61.5) | 20 (38.5) | |
| Tumour size | ||||
| < 3 cm | 55 (61.1) | 40 (72.7) | 15 (27.3) | 0.031 |
| ≥ 3 cm | 35 (38.9) | 12 (34.3) | 23 (65.7) | |
| Pathology stage | ||||
| pTa-pT1 | 57 (63.3) | 43 (75.3) | 14 (24.7) | 0.012 |
| pT2-T4 | 33 (36.7) | 9 (27.3) | 24 (72.7) | |
| Grade | ||||
| Low | 58 (64.4) | 41 (70.7) | 17 (29.3) | 0.014 |
| High | 32 (35.6) | 11 (34.4) | 21 (65.6) | |
| Lymphatic metastasis | ||||
| Yes | 19 (21.1) | 5 (26.3) | 14 (73.7) | 0.017 |
| No | 71 (78.9) | 47 (66.2) | 24 (33.8) | |
| Total | 90 | 52 | 38 | |